138 related articles for article (PubMed ID: 9130617)
1. Recent progress on the role of Axl, a receptor tyrosine kinase, in malignant transformation of myeloid leukemias.
Neubauer A; Burchert A; Maiwald C; Gruss HJ; Serke S; Huhn D; Wittig B; Liu E
Leuk Lymphoma; 1997 Mar; 25(1-2):91-6. PubMed ID: 9130617
[TBL] [Abstract][Full Text] [Related]
2. Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis.
Neubauer A; Fiebeler A; Graham DK; O'Bryan JP; Schmidt CA; Barckow P; Serke S; Siegert W; Snodgrass HR; Huhn D
Blood; 1994 Sep; 84(6):1931-41. PubMed ID: 7521695
[TBL] [Abstract][Full Text] [Related]
3. Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK).
Rochlitz C; Lohri A; Bacchi M; Schmidt M; Nagel S; Fopp M; Fey MF; Herrmann R; Neubauer A
Leukemia; 1999 Sep; 13(9):1352-8. PubMed ID: 10482985
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of the ufo/axl oncogene in human leukemia-lymphoma cell lines.
Challier C; Uphoff CC; Janssen JW; Drexler HG
Leukemia; 1996 May; 10(5):781-7. PubMed ID: 8656672
[TBL] [Abstract][Full Text] [Related]
5. Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia.
Hong CC; Lay JD; Huang JS; Cheng AL; Tang JL; Lin MT; Lai GM; Chuang SE
Cancer Lett; 2008 Sep; 268(2):314-24. PubMed ID: 18502572
[TBL] [Abstract][Full Text] [Related]
6. Activation of the Axl receptor tyrosine kinase induces mitogenesis and transformation in 32D cells.
McCloskey P; Pierce J; Koski RA; Varnum B; Liu ET
Cell Growth Differ; 1994 Oct; 5(10):1105-17. PubMed ID: 7848912
[TBL] [Abstract][Full Text] [Related]
7. Expression of the growth arrest-specific gene 6 (GAS6) in leukemia and lymphoma cell lines.
Dirks W; Rome D; Ringel F; Jäger K; MacLeod RA; Drexler HG
Leuk Res; 1999 Jul; 23(7):643-51. PubMed ID: 10400186
[TBL] [Abstract][Full Text] [Related]
8. The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development.
Park IK; Giovenzana C; Hughes TL; Yu J; Trotta R; Caligiuri MA
Blood; 2009 Mar; 113(11):2470-7. PubMed ID: 18840707
[TBL] [Abstract][Full Text] [Related]
9. Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion.
Wimmel A; Glitz D; Kraus A; Roeder J; Schuermann M
Eur J Cancer; 2001 Nov; 37(17):2264-74. PubMed ID: 11677117
[TBL] [Abstract][Full Text] [Related]
10. Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases.
Hafizi S; Dahlbäck B
Cytokine Growth Factor Rev; 2006 Aug; 17(4):295-304. PubMed ID: 16737840
[TBL] [Abstract][Full Text] [Related]
11. TAM receptors and the regulation of erythropoiesis in mice.
Tang H; Chen S; Wang H; Wu H; Lu Q; Han D
Haematologica; 2009 Mar; 94(3):326-34. PubMed ID: 19211638
[TBL] [Abstract][Full Text] [Related]
12. axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase.
O'Bryan JP; Frye RA; Cogswell PC; Neubauer A; Kitch B; Prokop C; Espinosa R; Le Beau MM; Earp HS; Liu ET
Mol Cell Biol; 1991 Oct; 11(10):5016-31. PubMed ID: 1656220
[TBL] [Abstract][Full Text] [Related]
13. GAS6, the ligand of Axl and Rse receptors, is expressed in hematopoietic tissue but lacks mitogenic activity.
Avanzi GC; Gallicchio M; Cavalloni G; Gammaitoni L; Leone F; Rosina A; Boldorini R; Monga G; Pegoraro L; Varnum B; Aglietta M
Exp Hematol; 1997 Nov; 25(12):1219-26. PubMed ID: 9357964
[TBL] [Abstract][Full Text] [Related]
14. Gas6 inhibits apoptosis in vascular smooth muscle: role of Axl kinase and Akt.
Melaragno MG; Cavet ME; Yan C; Tai LK; Jin ZG; Haendeler J; Berk BC
J Mol Cell Cardiol; 2004 Oct; 37(4):881-7. PubMed ID: 15380678
[TBL] [Abstract][Full Text] [Related]
15. CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia.
Gioia R; Trégoat C; Dumas PY; Lagarde V; Prouzet-Mauléon V; Desplat V; Sirvent A; Praloran V; Lippert E; Villacreces A; Leconet W; Robert B; Vigon I; Roche S; Mahon FX; Pasquet JM
J Pathol; 2015 Sep; 237(1):14-24. PubMed ID: 25965880
[TBL] [Abstract][Full Text] [Related]
16. A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control.
Budagian V; Bulanova E; Orinska Z; Thon L; Mamat U; Bellosta P; Basilico C; Adam D; Paus R; Bulfone-Paus S
EMBO J; 2005 Dec; 24(24):4260-70. PubMed ID: 16308569
[TBL] [Abstract][Full Text] [Related]
17. Gas6/AXL Signaling Regulates Self-Renewal of Chronic Myelogenous Leukemia Stem Cells by Stabilizing β-Catenin.
Jin Y; Nie D; Li J; Du X; Lu Y; Li Y; Liu C; Zhou J; Pan J
Clin Cancer Res; 2017 Jun; 23(11):2842-2855. PubMed ID: 27852702
[No Abstract] [Full Text] [Related]
18. Acidification prevents endothelial cell apoptosis by Axl activation.
D'Arcangelo D; Gaetano C; Capogrossi MC
Circ Res; 2002 Oct; 91(7):e4-12. PubMed ID: 12364394
[TBL] [Abstract][Full Text] [Related]
19. Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma.
Ben-Batalla I; Schultze A; Wroblewski M; Erdmann R; Heuser M; Waizenegger JS; Riecken K; Binder M; Schewe D; Sawall S; Witzke V; Cubas-Cordova M; Janning M; Wellbrock J; Fehse B; Hagel C; Krauter J; Ganser A; Lorens JB; Fiedler W; Carmeliet P; Pantel K; Bokemeyer C; Loges S
Blood; 2013 Oct; 122(14):2443-52. PubMed ID: 23982172
[TBL] [Abstract][Full Text] [Related]
20. Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemia.
Park IK; Mundy-Bosse B; Whitman SP; Zhang X; Warner SL; Bearss DJ; Blum W; Marcucci G; Caligiuri MA
Leukemia; 2015 Dec; 29(12):2382-9. PubMed ID: 26172401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
